Immunotherapy • Innovation • Translation

Pursuing a Brighter Future by Clearing Human Diseases

Advancing targeted vaccine and immunotherapy platforms inspired by the natural precision of the human immune system.

Explore Our Technology Contact Us
Our Vision

Precision-driven innovation for global health impact

We aim to bridge the gap between advanced immunology and real-world clinical translation.

NextGenVax is dedicated to developing breakthrough immunotherapies and vaccine technologies. By combining targeted immune activation, modular design, and translational strategy, we work to empower the immune system against infectious diseases and cancer with greater precision, accessibility, and clinical relevance.

Innovation Support

Translational Growth Support

NextGenVax is advancing a differentiated vaccine platform designed to address important limitations of conventional approaches.

Our innovation strategy focuses on scalable mucosal vaccine solutions that can be adapted across infectious disease and cancer applications, supporting faster development and broader future accessibility.

By building with translation in mind from the beginning, we strengthen readiness for preclinical validation, clinical development, and future partnering opportunities.

Translational Growth Support
Our Technology

Targeted Mucosal Platform

Our platform combines modular antigen design, immune-enhancing functionality, and targeted delivery concepts in a technology framework built for stronger local and systemic immunity.

Designed to reduce dependence on conventional needle-based administration, the platform supports more flexible development across multiple disease areas while maintaining a strong focus on manufacturability and translational potential.

This approach enables disease-relevant targeting, adaptable platform design, and improved readiness for future clinical and commercial development.

Leadership

Expert Scientific Leadership

Our advisory and leadership network brings together expertise across immunology, oncology, translational medicine, and biotechnology development.

This scientific depth supports our ability to connect complex molecular innovation with practical development pathways, helping ensure that promising technologies move toward meaningful patient impact.

NextGenVax scientific leadership
Operational Hub

Oslo Life Science Cluster

Located in the heart of Oslo’s life science environment, our operational base supports collaboration, research development, and international innovation engagement.

Oslo location

Targeted Immunity

Built to support stronger and more directed immune activation across relevant disease settings.

Modular Design

Flexible technology architecture adaptable across multiple infectious disease and oncology applications.

Translational Focus

Designed with preclinical validation, clinical readiness, and scale-up potential in mind.

Global Relevance

Created to support broader accessibility and future impact across diverse healthcare settings.